A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy

This publication has 12 references indexed in Scilit:

• Patterns of graft rejection following liver transplantation
  Journal of Hepatology, 1990
• INTRAVENOUS IMMUNOGLOBULIN INFUSIONS FOR THE PROPHYLAXIS OF SECONDARY CYTOMEGALOVIRUS INFECTION
  Transplantation, 1990
• Rejection in Liver Transplantation
  Hepatology, 1989
• A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts
  New England Journal of Medicine, 1989
• EPSTEIN-BARR VIRUS INFECTIONS FOLLOWING OKT3 TREATMENT
  Transplantation, 1989
• Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants
  Annals of Internal Medicine, 1988
• Pharmacokinetics and safety of high-dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation
  Clinical Pharmacology & Therapeutics, 1988
• Monoclonal Antibody Specificity: Orthoclone OKT3 T-Cell Blocker
  Nephron, 1987
• Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin
  The American Journal of Medicine, 1984
• A monoclonal antibody blocking human T cell function
  European Journal of Immunology, 1980